Characterization of salivary proteins of schizophrenic and bipolar disorder patients by top-down proteomics

Massimo Castagnola, Marianna Melis, Federica Iavarone, Giovanna Platania, Barbara Manconi, Tiziana Cabras, Raffaele Petruzzelli, Alberto Siracusano, Massimo Cordaro, Gavino Faa, Irene Messana, Marco Zanasi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

26 Citazioni (Scopus)


The analysis of whole saliva of 32 subjects with diagnosis of schizophrenia (SZ), 17 with diagnosis of bipolar disorder (BD), and 31 healthy subjects divided in non-smokers (HN; n=19) and smokers (HS; n=12) using an HPLC-ESI-MS top-down platform is reported in this study. Both SZ and BD revealed more than 10 fold mean increase of α-defensins 1-4, S100A12, cystatin A and S-derivatives of cystatin B levels with respect to the HN and HS control groups. No differences of protein levels were observed between SZ and BD groups and between HN and HS groups. Moreover, the correlation coefficients among the different proteins were significantly better in BD group than in SZ group. BIOLOGICAL SIGNIFICANCE: This study on whole saliva confirms a schizophrenia-associated dysregulation of immune pathway of peripheral white blood cells and suggests that the dysregulation of BD group could involve the activation of more specific cell type than that of SZ group.
Lingua originaleEnglish
pagine (da-a)N/A-N/A
RivistaJournal of Proteomics
Stato di pubblicazionePubblicato - 2014




Entra nei temi di ricerca di 'Characterization of salivary proteins of schizophrenic and bipolar disorder patients by top-down proteomics'. Insieme formano una fingerprint unica.

Cita questo